Novo Nordisk wins Dutch court injunction in semaglutide patent infringement case | live
STOCKHOLM, Aug 5 (Reuters) - Danish drugmaker Novo Nordisk said on Wednesday it had won a preliminary injunction against Ceban Ziekenhuisfarmacie B.V. from a district court in the Netherlands in a patent infringement case involving a compounded semaglutide nasal spray. (Reporting by Anna Ringstrom, editing by Elviira Luoma)
STOCKHOLM, Aug 5 (Reuters) - Danish drugmaker Novo Nordisk said on Wednesday it had won a preliminary injunction against Ceban Ziekenhuisfarmacie B.V. from a district court in the Netherlands in a patent infringement case involving a compounded semaglutide nasal spray. (Reporting by Anna Ringstrom, editing by Elviira Luoma)
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
